Efficacy Validation of Deep Microspicule Cream for Anti-aging and Whitening on Mature Skin
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-65
SponsorChung Shan Medical University
About this trial
This study is a single-center, prospective, split-face self-controlled pilot trial designed to evaluate the anti-aging and whitening efficacy of the "Deep Microspicule Cream" (containing patented crystal microspicules encapsulating Penghu seaweed extract) on mature skin.
Eligibility criteria
Qualifiers
Healthy male or female participants aged 40-65 years.
Presence of at least one facial aging or hyperpigmentation feature (e.g., eye area sagging, eye bags, crow's feet, fine lines, freckles, sun spots, uneven skin tone, or dullness).
Willing to complete 3 study visits within 4 weeks, comply with instrumental measurements, and maintain product logs.
Willing to sign the Informed Consent Form (ICF).
Disqualifiers
Received facial aesthetic treatments (e.g., lasers, chemical peels, microneedling, energy-based therapies) within 4 weeks.
Used topical/oral retinoic acid or strong whitening creams (e.g., high-concentration hydroquinone) within 4 weeks.
Severe sensitive skin, active atopic dermatitis, or obvious facial skin lesions/infections.
Facial salon or exfoliation treatments more frequent than once every 2 weeks.
Trial design
Treatments tested in this trial
- Deep Microspicule Cream
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov